About Bladder Cancer

According to the National Cancer Institute, bladder cancer is the fourth most common cancer in men in the United States and the eighth most common cancer in women. It is estimated that 67,160 new cases will be diagnosed in 2007.¹

Bladder cancer does not tend to run in families.³ However, smokers are more than twice as likely to get bladder cancer as nonsmokers. In addition, industrial chemicals found in dyes, rubber, leathers, textiles, and paint have been linked to bladder cancer.³

Many organizations offer support to patients as they face their diagnosis and treatment for cancer. Some of these groups are listed below.

The American Cancer Society
Phone: 1-800-ACS-2345
Website: www.cancer.org

The National Cancer Institute
Phone: 1-800-4-CANCER
Website: www.cancer.gov

American Urological Association
Website: www.urologyhealth.org

References:

1. How many people get bladder cancer? http://www.cancer.org. Accessed June 26, 2007.
2. Do we know what causes bladder cancer? http://www.cancer.org. Accessed June 26, 2007.
3. What are the risk factors for bladder cancer? http://www.cancer.org. Accessed June 26, 2007.
4. How is bladder cancer staged? http://www.cancer.org. Accessed June 26, 2007.
5. Surgery. http://www.cancer.org. Accessed June 26, 2007.
6. De Jager R, Guinan P, Lamm D, et al. Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Urology. 1991;38(6):507-513.
7. Lamm DL, Blumenstein BA, Crawford ED, et al. Randomized intergroup comparison of bacillus Calmette-Guérin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder. Urol Oncol. 1995;1(3):119-126.
8. BCG Live (For Intravesical Use) Tice® BCG [prescribing information]. Roseland, NJ: Organon USA Inc.
9. Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002;168:1964–1970.

 Send This Page to a Friend